Form 4 for GNTX GENTEX CORP
Accepted 2022-11-01 00:00:00 ET · period of report 2022-10-31 · accession 0001562180-22-007394 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-01 | 2022-10-31 | GNTX | Wallace James H | Dir | S - Sale+OE | $26.04 | -14.0K | 14.7K | -49% | -$364.6K |
| DM | 2022-11-01 | 2022-10-31 | GNTX | Wallace James H | Dir | M - OptEx | $21.45 | +14.0K | 21.7K | +182% | +$300.4K |
| DM | 2022-11-01 | 2022-10-31 | GNTX | Wallace James H | Dir | M - OptEx | $0.00 | -14.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-31 | S | D | 14,000 | $26.04 | 14,709 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $25.89 to $26.135. The price reported above reflects the weighted average price. |
| 2 | Common | Common Stock | 2022-10-31 | M | A | 7,000 | $24.21 | 28,709 | D | — | — | |
| 3 | Common | Common Stock | 2022-10-31 | M | A | 7,000 | $18.70 | 21,709 | D | — | — | |
| 4 | Derivative | Non-Employee Director Stock Option Grant | 2022-10-31 | M | D | 7,000 | $0.00 | 0 | D | $24.21 · 2018-11-17 to 2028-05-17 | 7,000 Common Stock | |
| 5 | Derivative | Non-Employee Director Stock Option Grant | 2022-10-31 | M | D | 7,000 | $0.00 | 0 | D | $18.70 · 2017-11-18 to 2027-05-18 | 7,000 Common Stock |